Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

CompletedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Spondylitis, Ankylosing
Interventions
DRUG

Enbrel

"The patients will be treated in accordance with the requirements of the labeling of Enbrel® in Austria. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.~To record complete dosing information, initial dose will be documented at baseline and any change will be documented with date, dose and reason at the subsequent visits."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY